Showing 1 - 9 results of 9 for search 'Benoît Kabamba-Mukadi', query time: 6.30s Refine Results
  1. 1
    First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium.

    First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium. by Géraldine Dessilly, Léonie Goeminne, Anne-Thérèse Vandenbroucke, François E Dufrasne, Anandi Martin, Benoît Kabamba-Mukadi

    Published 2018-01-01
    Get full text
    Article
  2. 2
    Low specificity of Aspergillus spp. ELITe MGB assay, and potential risks in management of invasive aspergillosis

    Low specificity of Aspergillus spp. ELITe MGB assay, and potential risks in management of invasive aspergillosis by Violaine Bothy, Maria A. Argudín, Nathalie Olive, Cindy Barbée, Benoît Kabamba-Mukadi, Hector Rodriguez-Villalobos

    Published 2024-03-01
    Get full text
    Article
  3. 3
    Correction: First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium.

    Correction: First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium. by Géraldine Dessilly, Léonie Goeminne, Anne-Thérèse Vandenbroucke, François E Dufrasne, Anandi Martin, Benoît Kabamba-Mukadi

    Published 2019-01-01
    Get full text
    Article
  4. 4
    Comparison of Sanger sequencing for hepatitis C virus genotyping with a commercial line probe assay in a tertiary hospital

    Comparison of Sanger sequencing for hepatitis C virus genotyping with a commercial line probe assay in a tertiary hospital by Sylvie Goletti, Siméon Zuyten, Léonie Goeminne, Chris Verhofstede, Hector Rodriguez-Villalobos, Monique Bodeus, Peter Stärkel, Yves Horsmans, Benoît Kabamba-Mukadi

    Published 2019-08-01
    Get full text
    Article
  5. 5
    The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium

    The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium by Laurence Geebelen, Tinne Lernout, Benoît Kabamba-Mukadi, Veroniek Saegeman, Hein Sprong, Steven Van Gucht, Philippe Beutels, Niko Speybroeck, Katrien Tersago

    Published 2017-08-01
    Get full text
    Article
  6. 6
    The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium

    The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium by Tinne Lernout, Benoît Kabamba-Mukadi, Veroniek Saegeman, Marie Tré-Hardy, Morgane de Laveleye, Tommi Asikainen, Ram Benny Dessau, Sophie Quoilin, Amber Litzroth

    Published 2019-05-01
    Get full text
    Article
  7. 7
    Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up

    Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up by Amber Litzroth, Vanessa Suin, Chloé Wyndham-Thomas, Sophie Quoilin, Gaëtan Muyldermans, Thomas Vanwolleghem, Benoît Kabamba-Mukadi, Vera Verburgh, Marjorie Jacques, Steven Van Gucht, Veronik Hutse

    Published 2019-01-01
    Get full text
    Article
  8. 8
    Evaluation of a commercial interferon-γ release assay for the detection of SARS-CoV-2 T-cell response after vaccination

    Evaluation of a commercial interferon-γ release assay for the detection of SARS-CoV-2 T-cell response after vaccination by Imane Saad Albichr, Samy Mzougui, Arnaud Devresse, Hélène Georgery, Eric Goffin, Nada Kanaan, Jean Cyr Yombi, Leila Belkhir, Julien De Greef, Anaïs Scohy, Hector Rodriguez-Villalobos, Benoît Kabamba-Mukadi

    Published 2023-06-01
    Get full text
    Article
  9. 9
    Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: a prospective cohort study in Belgium (2016–2020)

    Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: a prospective cohort study in Belgium (2016–2020) by Laurence Geebelen, Tinne Lernout, Brecht Devleesschauwer, Benoît Kabamba-Mukadi, Veroniek Saegeman, Leïla Belkhir, Paul De Munter, Bénédicte Dubois, Rene Westhovens, Humtick Hospital Group, Herman Van Oyen, Niko Speybroeck, Katrien Tersago

    Published 2022-09-01
    Get full text
    Article

Search Tools: